NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 75 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 443.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $28,791,237 | -18.3% | 9,111,151 | 0.0% | 0.96% | -6.0% |
Q2 2023 | $35,260,154 | +39.7% | 9,111,151 | 0.0% | 1.02% | +37.0% |
Q1 2023 | $25,237,888 | +53.9% | 9,111,151 | 0.0% | 0.74% | +61.6% |
Q4 2022 | $16,400,071 | -15.1% | 9,111,151 | 0.0% | 0.46% | -17.8% |
Q3 2022 | $19,315,000 | -21.2% | 9,111,151 | 0.0% | 0.56% | -27.0% |
Q2 2022 | $24,508,000 | -38.0% | 9,111,151 | 0.0% | 0.77% | -3.0% |
Q1 2022 | $39,542,000 | -58.1% | 9,111,151 | -50.0% | 0.79% | +8.8% |
Q4 2021 | $94,390,000 | +72.5% | 18,222,302 | +104.5% | 0.73% | -8.4% |
Q3 2021 | $54,714,000 | -69.6% | 8,911,151 | -50.0% | 0.80% | -32.0% |
Q2 2021 | $180,004,000 | – | 17,822,302 | – | 1.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AH Equity Partners Bio II, L.L.C. | 16,298,006 | $16,298,000 | 8.49% |
Madrona Venture Group, LLC | 6,020,770 | $31,188,000 | 5.89% |
ArchPoint Investors | 1,449,551 | $7,509,000 | 2.23% |
Ally Bridge Group (NY) LLC | 1,225,060 | $6,346,000 | 2.22% |
Affinity Asset Advisors, LLC | 1,049,721 | $5,438,000 | 1.98% |
Tikvah Management LLC | 1,231,835 | $6,381,000 | 1.78% |
Bain Capital Life Sciences Investors, LLC | 2,000,000 | $10,360,000 | 0.82% |
AH Equity Partners LSV II, L.L.C. | 1,355,911 | $1,356,000 | 0.74% |
Perceptive Advisors | 18,222,302 | $94,390,000 | 0.73% |
SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,144,000 | 0.46% |